Search Results

1-16 of 16 results for subject:ME/CFS

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Health, what programmes are in place for training doctors in treatment of myalgic encephalomyelitis. - Includes figure.

Asked by

Bill Wiggin (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

3 December 2003

Reference

141190; 415 c78W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will break down by region the £8.5 million announced on 12th May to provide services for patients with symptoms of myalgic encephalomyelitis/chronic fatigue syndrome.

Asked by

Anthony Steen (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

11 November 2003

Reference

413 c270W; 137820

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what guidance the NHS has issued to ensure that clinicians are fully informed in how to deal with patients presenting with chronic fatigue syndrome/myalgic encephalomyelitis. - Inc figures. (Holding answer 16 September 2003).

Asked by

John Baron (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

6 October 2003

Reference

130713; 410 c1271-2W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, What his policy is on the conclusion of the Donaldson Report on myalgic encephalitis/chronic fatigue syndrome. - Including figures. (Failed OPQ).

Asked by

Tom Clarke (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

1 July 2003

Reference

122434; 408 c225-6W;408 c226W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what consultations have taken place with the National Institute for Clinical Excellence on the Donaldson Report on ME; what consultations have taken place with the Medical Research Council on the Donaldson Report on ME; what action the Government has taken on the...

Asked by

Tom Clarke (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

30 June 2003

Reference

408 c162-3W; 117423;117424;117425

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what steps the Government is taking to improve facilities for people suffering from chronic fatigue syndrome; and if he will make a statement. - Inc figures.

Asked by

Joan Walley (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

11 June 2003

For answer on

13 June 2003

Answered on

13 June 2003

Ms Walley: To ask the Secretary of State for Health what steps the Government is taking to improve facilities for people suffering from chronic fatigue syndrome; and if he will make a statement. [119390] Jacqui Smith: In our response to the independent working group's report on chronic fatigue syndrome/ myalgic encephalomyelitis (CFS/ME) in January 2002 we endorsed their view that there should be no doubt this is a chronic illness and that health and social care professionals should recognise it as such. On 12 May we announced that funding of £8.5 million would be provided to develop services for people with CFS/ME. In July health organisations will be invited to bid for development funds to set up centres of expertise to develop clinical care, support clinical research and expand education and training programmes for health care professionals and to establish satellite community multidisciplinary teams. The first phase of development will commence in April 2004. We asked the Medical Research Council to develop a research strategy for advancing biomedical and health services research on CFS/ME. The MRC published their research strategy for CFS/ ME on 1 May. The strategy will enable researchers and funders to develop research proposals on all aspects of this illness. It was developed by an independent research advisory group in response to a request from the Chief Medical Officer, and was informed by contributions from patients, carers, charities, researchers and clinicians via a consultation exercise in summer 2002. The MRC has announced two initiatives in response to the strategy. One is a notice to the research community welcoming high quality proposals across the entire spectrum of CFS/ME research. The other is a scientific meeting to discuss the potential to use existing UK resources and infrastructures to undertake epidemiological studies in this country. In May 2003 the MRC announced funding for two trials that will look at the effectiveness of various treatments for CFS/ME. The results of these trials will help patients and their doctors to choose the best treatment. These complementary trials will assess a variety of treatments and in doing so will both help address important issues for those with CFS/ME. The first trial known as PACE (Pacing, Activity and Cognitive behaviour therapy: a randomised Evaluation) will make the first assessment of a treatment choice popular with patients called `Pacing'. The second trial, known as FINE, (Fatigue Intervention by Nurses Evaluation) will test two different treatments that are particularly suited to helping reach those who are too ill to attend a specialist clinic as patients will be treated by nurses in their own homes.

Date

13 June 2003

Reference

119390; 406 c1125-6W;406 c1127-8W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what guidance his Department gives to the NHS about the treatment of ME. - Inc figure.

Asked by

Lord Grayling (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

3 June 2003

For answer on

9 June 2003

Answered on

9 June 2003

Chris Grayling: To ask the Secretary of State for Health what guidance his Department gives to the NHS about the treatment of ME. [117202] Jacqui Smith: We have issued no guidance to the National Health Service on the treatment of patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). We are, however, taking steps to improve services for patients with this condition. On 12 May, we announced funding of £8.5 million that will be used to develop services for people with CFS/ME. In July, health organisations will be invited to bid for development funds to set up centres of expertise to develop clinical care, support clinical research and expand education and training programmes for health care professionals and to establish satellite community multidisciplinary teams. The first phase of development will commence in April 2004. We have issued no guidance to hospital trusts and Primary Care Trusts on the provision of services to patients with CFS/ME. The main Government agency for research into the causes and treatment of disease is the Medical Research Council (MRC), which receives its funding from the Department of Trade and Industry via the Office of Science and Technology. The MRC published a research strategy for CFS/ME on 1 May. The strategy will enable researchers and funders to develop research proposals on all aspects of this illness. It was developed by an independent research advisory group in response to a request from the Chief Medical Officer and was informed by contributions from patients, carers, charities, researchers and clinicians via a consultation exercise in summer 2002. The MRC has announced two initiatives in response to the strategy. One is a notice to the research community welcoming high quality proposals across the entire spectrum of CFS/ME research. The other is a scientific meeting to discuss the potential to use existing UK resources and infrastructures to undertake epidemiological studies in this country. In addition, the MRC announced funding, on 15 May 2003, for two trials that will look at the effectiveness of various treatments for CFS/ME. The results of these trials will help patients and their doctors to choose the best treatment. These complementary trials will assess a variety of treatments and in doing so will both help address important issues for those with CFS/ME. The first trial known as PACE (Pacing, Activity and Cognitive behaviour therapy: a randomised Evaluation) will make the first assessment of a treatment choice popular with patients called `Pacing'. The second trial, known as FINE, (Fatigue Intervention by Nurses Evaluation) will test two different treatments that are particularly suited to helping reach those who are too ill to attend a specialist clinic as patients will be treated by nurses in their own homes.

Date

9 June 2003

Reference

117202; 406 c689-90W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what recommendations have been made by the Chief Medical Officer to treat symptoms of myalgic encephalomyelitis. - Includes figures and ref to 405 c610-1W, 19 May 2003.

Asked by

Anthony Steen (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

3 June 2003

Reference

113797; 406 c369-70W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what plans there are to recruit specialists to whom GPs can refer patients with symptoms of myalgic encephalomyelitis; and if he will make a statement. - (Holding answer 19 May 2003).

Asked by

Anthony Steen (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

13 May 2003

For answer on

3 June 2003

Answered on

3 June 2003

Mr. Steen: To ask the Secretary of State for Health what plans there are to recruit specialists to whom GPs can refer patients with symptoms of myalgic encephalomyelitis; and if he will make a statement. [113798] Jacqui Smith :[holding answer 19 May 2003]: Decisions on the staffing configuration for treating particular patient groups, including those with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ ME), are best made at a local level. We are however, taking steps to improve services for patients with CFS/ME. I announced funding of £8.5 million on 12 May to develop services for people with CFS/ME. The Medical Research Council (MRC) published a research strategy for CFS/ME on 1 May. The strategy will enable researchers and funders to develop research proposals on all aspects of this illness. It was developed by an independent research advisory group in response to a request from the Chief Medical Officer and was informed by contributions from patients, carers, charities, researchers and clinicians via a consultation exercise in summer 2002. The MRC has announced two initiatives in response to the strategy. One is a notice to the research community welcoming high quality proposals across the entire spectrum of CFS/ME research. The other is a scientific meeting to discuss the potential to use existing United Kingdom resources and infrastructures to undertake epidemiological studies in this country. In addition, the MRC has just announced funding, on 15 May 2003, for two trials that will look at the effectiveness of various treatments for CFS/ME. The results of these trials will help patients and their doctors to choose the best treatment. These complementary trials will assess a variety of treatments and in doing so will both help address important issues for those with CFS/ME. The first trial, known as PACE--"Pacing, Activity and Cognitive behaviour therapy: a randomised Evaluation"--will make the first assessment of a treatment choice popular with patients called "Pacing". The second trial, known as FINE--"Fatigue Intervention by Nurses Evaluation"--will test two different treatments that are particularly suited to helping reach those who are too ill to attend a specialist clinic as patients will be treated by nurses in their own homes.

Date

3 June 2003

Reference

113798; 406 c370W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how the funding announced on 12th May for service development for people with myalgic encephalomyelitis and chronic fatigue syndrome will be distributed; what assessment he has made of the level and range of service provision for people with myalgic encephalomyelitis and chronic...

Asked by

Paul Burstow (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

21 May 2003

Reference

405 c856W; 113655;113534

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will commission a research project into myalgic encephalomyelitis and the (a) suspected causes, (b) the scale of the problem, (c) the treatments available and (d) the number of specialists employed by the NHS to whom GPs can refer patients with...

Asked by

Anthony Steen (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

13 May 2003

For answer on

19 May 2003

Answered on

19 May 2003

Mr. Steen: To ask the Secretary of State for Health if he will commission a research project into myalgic encephalomyelitis and the (a) suspected causes, (b) the scale of the problem, (c) the treatments available and (d) the number of specialists employed by the NHS to whom GPs can refer patients with ME-like symptoms. [113800] Jacqui Smith: The main Government agency for research into the causes and treatment of disease is the Medical Research Council (MRC), which receives its funding from the Department of Trade and Industry via the Office of Science and Technology. The MRC published a research strategy for cnronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) on 1 May. The strategy will enable researchers and funders to develop research proposals on all aspects of this illness. It was developed by an independent research advisory group in response to a request from the Chief Medical Officer, and was informed by contributions from pstients, carers, charities, researchers and clincians via a consultation exercise in summer 2002. The MRC has announced two initiatives in response to the strategy. One is a notice to the research community welcoming high quality proposals across the entire spectrum of CFS/ME research. The other is a scientific meeting to discuss the potential to use existing UK resources and infrastructures to undertake epidemiological studies in this country. In addition, the MRC has just announced funding for two trials that will look at the effectiveness of various treatments for CFS/ ME. The results of these trials will help patients and their doctors to choose the best treatment. These complementary trials will assess a variety of treatments and in doing so will both help address important issues for those with CFS/ME. The first trial known as PACE (Pacing, Activity and Cognitive behaviour therapy a randomised Evaluation) will make the first assessment of a treatment choice popular with patients called `Pacing'. The second trial, known as FINE, (Fatigue Intervention by Nurses Evaluation) will test two different treatments that are particularly suited to helping reach those who are too ill to attend a specialist clinic as patients will be treated by nurses in their own homes.

Date

19 May 2003

Reference

113800; 405 c610-1W;405 c608-9W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what targets he has to increase awareness of myalgic encephalomyelitis; and if he will make a statement; if he will make a statement on regional variations in the incidence of myalgic encephalomyelitis. - Inc figures and ref to the report of the...

Asked by

Vincent Cable (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

19 May 2003

Reference

405 c610W;405 c608W; 113044;113045

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what treatments the NHS provides for patients with ME; and what rehabilitation courses the NHS offers to such patients. - (Holding answer 1 May 2003).

Asked by

Lord Grayling (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

8 May 2003

Reference

110837; 404 c871W;404 c868W

House

House of Commons

Dept for Work and Pensions

To ask the Secretary of State for Work and Pensions, if he will make a statement about the eligibility of sufferers of ME for incapacity benefit.

Asked by

Peter Luff (Conservative)

Answering body

Department for Work and Pensions

Type

Written questions

Status

Answered

Date

14 April 2003

Reference

108144; 403 c644W;403 c644-5W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many myalgic encephalomyelitis/chronic fatigue syndrome sufferers there are in England; how many of them are receiving treatment from the NHS; and if he will make a statement. - Inc figures.

Asked by

Vincent Cable (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

12 February 2003

Reference

97504; 399 c811W;399 c809W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what recent guidance he has issued to hospital trusts and PCTs on the provision of services to myalgic encephalomyelitis/chronic fatigue syndrome sufferers; and if he will make a statement.

Asked by

Vincent Cable (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

12 February 2003

Reference

97505; 399 c811-2W;399 c809-10W

House

House of Commons

Librarians' tools

Type

House

Session

Month

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher